Current Opinion in Drug Discovery & Development
Archive
Current Opinion in Drug Discovery & Development, Volume 5
Paper alert J Hirst, P Norman Current Opinion in Drug Discovery & Development 2002, 5 :1-19 (15 [Abstract ] [Full text ] [PDF ]
Patent alert B Swords Current Opinion in Drug Discovery & Development 2002, 5 :20-28 (15 [Abstract ] [Full text ] [PDF ]
The chemistry of metabolic and toxicological processes D Cavalla Current Opinion in Drug Discovery & Development 2002, 5 :29-30 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The chemistry of metabolic and toxicological processes DE Johnson, DA Smith, BK Park Current Opinion in Drug Discovery & Development 2002, 5 :31-32 (15 [Abstract ] [Full text ] [PDF ]
High-throughput and in silico techniques in drug metabolism and pharmacokinetics H van de Waterbeemd Current Opinion in Drug Discovery & Development 2002, 5 :33-43 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Evolutionary computational methods to predict oral bioavailability QSPRs W Bains, R Gilbert, L Sviridenko, JM Gascon, R Scoffin, K Birchall, I Harvey, J Caldwell Current Opinion in Drug Discovery & Development 2002, 5 :44-51 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Automated sample preparation and LC-MS for high-throughput ADME quantification D O'Connor Current Opinion in Drug Discovery & Development 2002, 5 :52-58 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Intravenous administration of poorly soluble new drug entities in early drug discovery: The potential impact of formulation on pharmacokinetic parameters B Bittner, RJ Mountfield Current Opinion in Drug Discovery & Development 2002, 5 :59-71 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Increasing throughput in lead optimization in vivo toxicity screens V Meador, W Jordan, J Zimmermann Current Opinion in Drug Discovery & Development 2002, 5 :72-78 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Gene expression profiling for pharmaceutical toxicology screening PJ Bugelski Current Opinion in Drug Discovery & Development 2002, 5 :79-89 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Transcriptomics in predictive toxicology T Storck, Brevern MC von, CK Behrens, J Scheel, A Bach Current Opinion in Drug Discovery & Development 2002, 5 :90-97 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Analysis of gene and protein expression for drug mode of toxicity LM Furness Current Opinion in Drug Discovery & Development 2002, 5 :98-103 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Toxicophores: Groups and metabolic routes associated with increased safety risk DP Williams, DJ Naisbitt Current Opinion in Drug Discovery & Development 2002, 5 :104-115 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Towards a drug concentration effect relationship for QT prolongation and torsades de pointes R Webster, D Leishman, D Walker Current Opinion in Drug Discovery & Development 2002, 5 :116-126 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Models for profiling the potential QT prolongation risk of drugs AL Muzikant, RC Penland Current Opinion in Drug Discovery & Development 2002, 5 :127-135 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Improving structure-linked access to publicly available chemical toxicity information AM Richard, CR Williams, NF Cariello Current Opinion in Drug Discovery & Development 2002, 5 :136-143 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Genotype/phenotype comparisons: A probe for the effect of disease progression on drug metabolism ML Williams, IW Wainer Current Opinion in Drug Discovery & Development 2002, 5 :144-149 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Structural insights into the promiscuity and function of the human pregnane X receptor RE Watkins, SM Noble, MR Redinbo Current Opinion in Drug Discovery & Development 2002, 5 :150 (15 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2002, 5 :159-177 (12 [Abstract ] [Full text ] [PDF ]
Patent alert B Swords Current Opinion in Drug Discovery & Development 2002, 5 :178-188 (12 [Abstract ] [Full text ] [PDF ]
The chemistry of biological products. D Cavalla Current Opinion in Drug Discovery & Development 2002, 5 :189-190 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The chemistry of biological processes. J McAlpine, K Culver, D Ecker Current Opinion in Drug Discovery & Development 2002, 5 :191-193 (12 [Abstract ] [Full text ] [PDF ]
Live bacteria as anticancer agents and tumor-selective protein delivery vectors. D Bermudes, L Zheng, IC King Current Opinion in Drug Discovery & Development 2002, 5 :194-199 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The genus Bifidobacterium for cancer gene therapy. M Fujimori, J Amano, S Taniguchi Current Opinion in Drug Discovery & Development 2002, 5 :200-203 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recombinant antibodies for the selective targeting of tumor neovasculature. F Viti, L Giovannoni, D Neri Current Opinion in Drug Discovery & Development 2002, 5 :204-213 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Inhibitors of growth factor receptor kinase-dependent signaling pathways in anticancer chemotherapy - clinical progress. P Renhowe Current Opinion in Drug Discovery & Development 2002, 5 :214-224 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Current progress on farnesyl protein transferase inhibitors. SB Singh, RB Lingham Current Opinion in Drug Discovery & Development 2002, 5 :225-244 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Recent developments in peptide-based cancer therapeutics. A Sehgal Current Opinion in Drug Discovery & Development 2002, 5 :245-250 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The cyclotides: Novel macrocyclic peptides as scaffolds in drug design. DJ Craik, S Simonsen, NL Daly Current Opinion in Drug Discovery & Development 2002, 5 :251-260 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Therapeutic applications of guanylate cyclase-C receptor agonists. K Shailubhai Current Opinion in Drug Discovery & Development 2002, 5 :261-268 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Bacterial toxins as versatile delivery vehicles. L deHaan, TR Hirst Current Opinion in Drug Discovery & Development 2002, 5 :269-278 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Drug delivery systems based on sugar-macromolecule conjugates. BG Davis, MA Robinson Current Opinion in Drug Discovery & Development 2002, 5 :279-288 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Use of HSV vectors to modify the nervous system. JC Glorioso, DJ Fink Current Opinion in Drug Discovery & Development 2002, 5 :289-295 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Plant cell cultures as a source of bioactive small molecules. AM Stafford Current Opinion in Drug Discovery & Development 2002, 5 :296-303 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Mother nature's combinatorial libraries; their influence on the synthesis of drugs. DGI Kingston, DJ Newman Current Opinion in Drug Discovery & Development 2002, 5 :304-316 (12 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Erratum: William Bains, Richard Gilbert, Lilya Sviridenko, Jose-Miguel Gascon, Robert Scoffin, Kris Birchall, Lesley Hetherington, Inman Harvey & John Caldwell: Evolutionary computational methods to predict oral bioavailability QSPRs. Curr Opin Drug Discovery Dev (2002) 5(1):44-51. Current Opinion in Drug Discovery & Development 2002, 5 :317 (12 [Abstract ] [Full text ] [PDF ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2002, 5 :319-338 (14 [Abstract ] [Full text ] [PDF ]
Patent alert B Swords Current Opinion in Drug Discovery & Development 2002, 5 :339-351 (14 [Abstract ] [Full text ] [PDF ]
The management of chemical and biological information D Cavalla Current Opinion in Drug Discovery & Development 2002, 5 :352-353 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Discovery systems integration: Is it strategic or tactical? P Gund, F Brown, E Maliski Current Opinion in Drug Discovery & Development 2002, 5 :354 (14 [Abstract ] [Full text ] [PDF ]
Global analysis of large-scale chemical and biological experiments DE Root, BP Kelley, BR Stockwell Current Opinion in Drug Discovery & Development 2002, 5 :355-360 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Component architecture in drug discovery informatics PM Smith Current Opinion in Drug Discovery & Development 2002, 5 :361-366 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Structural genomics: Bridging functional genomics and structure-based drug design SG Buchanan Current Opinion in Drug Discovery & Development 2002, 5 :367-381 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Progress in computational methods for the prediction of ADMET properties DE Clark, PDJ Grootenhuis Current Opinion in Drug Discovery & Development 2002, 5 :382-390 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Fragment analysis in small molecule discovery C Meriot, D Domine, DJ Church Current Opinion in Drug Discovery & Development 2002, 5 :391-399 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Knowledge-based approaches in the design and selection of compound libraries for drug discovery VN Viswanadhan, C Balan, C Hulme, JC Cheetham, Y Sun Current Opinion in Drug Discovery & Development 2002, 5 :400-406 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Structure-based approaches to drug design and virtual screening B Waszkowycz Current Opinion in Drug Discovery & Development 2002, 5 :407-413 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
High-throughput virtual screening for drug discovery in parallel LM Toledo-Sherman, D Chen Current Opinion in Drug Discovery & Development 2002, 5 :414-421 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Initial compound selection for sequential screening SS Young, RLH Lam, WJ Welch Current Opinion in Drug Discovery & Development 2002, 5 :422-427 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Multiscale and Bayesian approaches to data analysis in genomics high- throughput screening C Yang, BR Bakshi, JF Rathman, PE Blower Current Opinion in Drug Discovery & Development 2002, 5 :428-438 (14 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2002, 5 :439-458 (31 [Abstract ] [Full text ] [PDF ]
Patent alert B Swords Current Opinion in Drug Discovery & Development 2002, 5 :459-472 (31 [Abstract ] [Full text ] [PDF ]
Web alert D Cavalla Current Opinion in Drug Discovery & Development 2002, 5 :473-474 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Chemical genomics, pharmacogenomics and pharmacogenetics. WJ Greenlee, MC Desai Current Opinion in Drug Discovery & Development 2002, 5 :475-476 (31 [Abstract ] [Full text ] [PDF ]
Osteoporosis: Challenges and new opportunities for therapy. DP Rotella Current Opinion in Drug Discovery & Development 2002, 5 :477-486 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent advances in the discovery of small molecule histone deacetylase inhibitors. SW Remiszewski Current Opinion in Drug Discovery & Development 2002, 5 :487-499 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes. JF Tobin, S Tam Current Opinion in Drug Discovery & Development 2002, 5 :500-512 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent advances in the development of g-secretase inhibitors. H Josien Current Opinion in Drug Discovery & Development 2002, 5 :513-525 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Drug discovery and development using chemical genomics. A Sehgal Current Opinion in Drug Discovery & Development 2002, 5 :526-531 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Chemical genomics: Bridging the gap between the proteome and therapeutics. D Falb, S Jindal Current Opinion in Drug Discovery & Development 2002, 5 :532-539 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Guiding molecules towards drug-likeness. WJ Egan, WP Walters, MA Murcko Current Opinion in Drug Discovery & Development 2002, 5 :540-549 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Designing selective COX-2 inhibitors: Molecular modeling approaches. G Trummlitz, Ryn J van Current Opinion in Drug Discovery & Development 2002, 5 :550-561 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Microsomal triglyceride transfer protein (MTP) inhibitors: Discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms. G Chang, RB Ruggeri, Jr HJ Harwood Current Opinion in Drug Discovery & Development 2002, 5 :562-570 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
New developments in chemical library synthesis. Norbornenyl tags for use in phase-switching,
sequestration, capture-release and soluble support applications. DL Flynn, PR Hanson, SC Berk, GM Makara Current Opinion in Drug Discovery & Development 2002, 5 :571-579 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent advances in chemical library synthesis methodology. DL Flynn, SC Berk, GM Makara Current Opinion in Drug Discovery & Development 2002, 5 :580-593 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Solid-phase compound library synthesis in drug design and development. PJ Edwards, AI Morrell Current Opinion in Drug Discovery & Development 2002, 5 :594-605 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Membrane array technology for drug discovery. JT Groves Current Opinion in Drug Discovery & Development 2002, 5 :606-612 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Using X-ray crystallography in drug discovery. RS Rowland Current Opinion in Drug Discovery & Development 2002, 5 :613-619 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent trends in microwave-assisted synthesis. NS Wilson, GP Roth Current Opinion in Drug Discovery & Development 2002, 5 :620-629 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
NMR-based approaches for lead discovery. DF Wyss, MA McCoy, MM Senior Current Opinion in Drug Discovery & Development 2002, 5 :630-647 (31 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2002, 5 :649-667 (18 [Abstract ] [Full text ] [PDF ]
Patent alert B Swords Current Opinion in Drug Discovery & Development 2002, 5 :668-678 (18 [Abstract ] [Full text ] [PDF ]
Web alert D Cavalla Current Opinion in Drug Discovery & Development 2002, 5 :679-680 (18 [Abstract ] [Full text ] [PDF ]
The chemistry of biological processes. JA Lowe, CH Hill, FD King Current Opinion in Drug Discovery & Development 2002, 5 :681-682 (18 [Abstract ] [Full text ] [PDF ]
Integrated approaches to therapeutic target gene discovery. KM DeFife, F Wong-Staal Current Opinion in Drug Discovery & Development 2002, 5 :683-689 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Aptamers and aptazymes: Accelerating small molecule drug discovery. P Burgstaller, A Jenne, M Blind Current Opinion in Drug Discovery & Development 2002, 5 :690-700 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Targeting protein kinases in cancer therapy. D Fabbro, C Garcia-Echeverria Current Opinion in Drug Discovery & Development 2002, 5 :701-712 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Kinases as targets: Prospects for chronic therapy. S Orchard Current Opinion in Drug Discovery & Development 2002, 5 :713-717 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Protein kinase inhibitors from the urea class. J Dumas Current Opinion in Drug Discovery & Development 2002, 5 :718-727 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Bioactive lipids and their receptors. I Angel, A Bar, R Haring Current Opinion in Drug Discovery & Development 2002, 5 :728-740 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
The inner workings of AMPA receptors. DR Madden Current Opinion in Drug Discovery & Development 2002, 5 :741-748 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Allosteric modulation of G protein-coupled receptors. W Soudjin, Wijngaarden I van, AP IJzerman Current Opinion in Drug Discovery & Development 2002, 5 :749-755 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Formation of oligomers by G protein-coupled receptors. L Gazi, JF Lopez-Gimenez, PG Strange Current Opinion in Drug Discovery & Development 2002, 5 :756-763 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. P Kitabgi Current Opinion in Drug Discovery & Development 2002, 5 :764-776 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Internal initiation of translation by viral and cellular IRESs - A new avenue for specific inhibition of protein synthesis? J Gallego Current Opinion in Drug Discovery & Development 2002, 5 :777-784 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Novel approaches to antimicrobial therapy: Peptide deformylase. AS Waller, JM Clements Current Opinion in Drug Discovery & Development 2002, 5 :785-792 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
New approaches to reversal of neuromuscular block. A Bom, JK Clark, R Palin Current Opinion in Drug Discovery & Development 2002, 5 :793-800 (18 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Paper alert J Hirst, P Norman, DP Rotella Current Opinion in Drug Discovery & Development 2002, 5 :801-817 (20 [Abstract ] [Full text ] [PDF ]
Patent alert B Swords Current Opinion in Drug Discovery & Development 2002, 5 :818-829 (20 [Abstract ] [Full text ] [PDF ]
Web alert D Cavalla Current Opinion in Drug Discovery & Development 2002, 5 :830-831 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Editorial overview RN Landau, PN Confalone, JA Grosso Current Opinion in Drug Discovery & Development 2002, 5 :832-833 (20 [Abstract ] [Full text ] [PDF ]
Scalable enantioselective processes for chiral pharmaceutical intermediates. T Lida, T Mase Current Opinion in Drug Discovery & Development 2002, 5 :834-851 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Development of an atropselective methodology for axially chiral biaryls in the asymmetric synthesis of A-240610.0. Y Ku, T Grieme Current Opinion in Drug Discovery & Development 2002, 5 :852-859 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Catalytic enantioselective oxidations using molecular oxygen. MS Sigman, DR Jensen, S Rajaram Current Opinion in Drug Discovery & Development 2002, 5 :860-869 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Synthetic applications of chiral 2,3-dihydro-4-pyridones. S Joseph, DL Comins Current Opinion in Drug Discovery & Development 2002, 5 :870-880 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
New methodology for the asymmetric reduction of ketones. M Wills, J Hannedouche Current Opinion in Drug Discovery & Development 2002, 5 :881-891 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Asymmetric hydrogenation and other methods for the synthesis of unnatural amino acids and derivatives. DJ Ager Current Opinion in Drug Discovery & Development 2002, 5 :892-905 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Selective functionalization of small organic molecules using electrophilic nitrogen sources. IDG Watson, AK Yudin Current Opinion in Drug Discovery & Development 2002, 5 :906-917 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Aziridines and aziridinium ions in the practical synthesis of pharmaceutical intermediates - A perspective. VH Dahanukar, LA Zavialov Current Opinion in Drug Discovery & Development 2002, 5 :918-927 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Stereoselective transition metal-catalyzed and radical polycyclizations. C Aubert, C Courillon, A Dhimane, L Fensterbank, E Lacote, S Thorimbert, M Malacria Current Opinion in Drug Discovery & Development 2002, 5 :928-936 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Heavy-metal complexation by de novo peptide design. BT Farrer, VL Pecoraro Current Opinion in Drug Discovery & Development 2002, 5 :937-943 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Synthetic approaches to the microtubule stabilizing agent (-)-laulimalide. MT Crimmins Current Opinion in Drug Discovery & Development 2002, 5 :944-959 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Scale-up of polymerization processes. T Meyer Current Opinion in Drug Discovery & Development 2002, 5 :960-965 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Heterogeneously functionalized dendrimers. JR Morgan, MJ Cloninger Current Opinion in Drug Discovery & Development 2002, 5 :966-973 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Selective RXR modulators for the treatment of type II diabetes. MM Faul, TA Grese Current Opinion in Drug Discovery & Development 2002, 5 :974-985 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Recent developments in the construction of trans-fused polycyclic ethers. PA Evans, B Delouvrie Current Opinion in Drug Discovery & Development 2002, 5 :986-999 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Innovative oxidation methods in fine chemicals synthesis. P Poechlauer, W Skranc Current Opinion in Drug Discovery & Development 2002, 5 :1000-1008 (20 [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Erratum Current Opinion in Drug Discovery & Development 2002, 5 :1009 (20 [Abstract ] [Full text ] [PDF ]
Current Opinion in Drug Discovery & Development Volumes
previous issue
January